R 1485Alternative Names: GPCR modulator; R1485
Latest Information Update: 13 Jul 2006
At a glance
- Originator Roche
- Mechanism of Action G protein-coupled receptor modulators
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
On Fast track
Fast track status is assigned by the US FDA so therapies with the potential to address unmet needs can move faster through development.
Highest Development Phases
- No development reported Alzheimer's disease
Most Recent Events
- 26 Apr 2004 Phase-I clinical trials in Alzheimer's disease in Europe (PO)
- 24 Nov 2003 Preclinical trials in Alzheimer's disease in Europe (PO)